Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Solasto Corporation (6197.T)
JPY1,110.00
-1.00 (-0.09%)
JP JPX Healthcare Medical - Care Facilities
Address
1-7-18 Konan 108-8210
Tokyo, JP
Tokyo, JP
CEO
Toru Noda
Website
solasto.co.jp
IPO
2016-06-29
ISIN JP3436250009
Description
Solasto Corporation, which began operations in 1965 in Tokyo, Japan (originally under the name N.I.C Corporation), primarily concentrates on providing outsourced support services to healthcare institutions across Japan. A significant aspect of its medical offerings involves handling administrative and clerical duties for these facilities on a contractual basis. Beyond its core medical services, Solasto also extends its expertise to elder care, offering a variety of solutions such as daily activity programs, home assistance, and residential care. Furthermore, the company manages childcare services and is involved in the education sector.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY1,110.00
-1.00 (-0.09%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
398.6K
Beta
0.38
Float Shares
47.50M
Free Float %
52.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.27% | -0.18% | -0.09% | +19.51% | +117.35% | +29.80% | +161.12% | +74.49% | -14.95% | +206.60% | +206.60% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1,110.00
DCF (Unlevered)
2,295.43
+106.8%
DCF (Levered)
2,521.76
+127.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
4.47
Safe zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+2.7% Q1'26: +3.0% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-4.9% Q1'26: -72.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+4.7% Q1'26: +3.8% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+5.2% Q1'26: +5.2% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+15.0% ★ Q1'26: +15.0% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-0.7% ★ Q1'26: -6.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.73× ★ Q1'26: 1.73× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 3 EPS Ana. |
Mar 2027 3 Rev. Ana. 3 EPS Ana. |
Mar 2028 3 Rev. Ana. 3 EPS Ana. |
Mar 2029 2 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
65.41B
est: 65.95B (-0.8%)
|
74.33B
est: 71.57B (+3.9%)
|
84.25B
est: 84.88B (-0.7%)
|
95.72B
est: 95.27B (+0.5%)
|
106.18B
est: 104.49B (+1.6%)
|
117.24B
est: 114.46B (+2.4%)
|
131.09B
est: 127.21B (+3.0%)
|
135.14B
est: 136.32B (-0.9%)
|
137.44B
est: 137.35B (+0.1%)
|
140.95B
140.62B – 141.16B
+2.6% YoY
|
145.75B
143.93B – 146.90B
+3.4% YoY
|
150.10B
146.65B – 153.24B
+3.0% YoY
|
147.74B
145.10B – 149.88B
-1.6% YoY
|
157.00B
154.20B – 159.28B
+6.3% YoY
|
| EBITDA |
4.23B
est: 4.53B (-6.5%)
|
5.20B
est: 4.91B (+5.7%)
|
6.54B
est: 5.83B (+12.3%)
|
7.42B
est: 6.54B (+13.4%)
|
8.40B
est: 7.17B (+17.1%)
|
8.92B
est: 7.86B (+13.5%)
|
9.46B
est: 8.73B (+8.3%)
|
8.86B
est: 9.99B (-11.4%)
|
10.13B
est: 10.07B (+0.6%)
|
10.33B
10.31B – 10.35B
+2.6% YoY
|
10.69B
10.55B – 10.77B
+3.4% YoY
|
11.00B
10.75B – 11.23B
+3.0% YoY
|
10.83B
10.64B – 10.99B
-1.6% YoY
|
11.51B
11.31B – 11.68B
+6.3% YoY
|
| EBIT |
3.65B
est: 3.01B (+21.6%)
|
4.19B
est: 3.26B (+28.5%)
|
5.03B
est: 3.87B (+30.1%)
|
5.47B
est: 4.34B (+25.9%)
|
6.06B
est: 4.76B (+27.3%)
|
6.32B
est: 5.22B (+21.2%)
|
6.33B
est: 5.80B (+9.1%)
|
5.52B
est: 6.85B (-19.4%)
|
7.02B
est: 6.90B (+1.7%)
|
7.08B
7.06B – 7.09B
+2.6% YoY
|
7.32B
7.23B – 7.38B
+3.4% YoY
|
7.54B
7.37B – 7.70B
+3.0% YoY
|
7.42B
7.29B – 7.53B
-1.6% YoY
|
7.89B
7.75B – 8.00B
+6.3% YoY
|
| Net Income |
2.47B
est: 2.42B (+2.1%)
|
2.71B
est: 2.77B (-2.2%)
|
3.51B
est: 3.45B (+1.6%)
|
4.74B
est: 5.06B (-6.3%)
|
3.54B
est: 3.70B (-4.4%)
|
3.50B
est: 4.30B (-18.5%)
|
3.17B
est: 4.10B (-22.6%)
|
2.26B
est: -280.00M (+906.1%)
|
3.96B
est: 4.03B (-1.7%)
|
4.40B
4.21B – 4.61B
+9.2% YoY
|
4.48B
4.09B – 4.87B
+1.8% YoY
|
3.93B
2.87B – 6.11B
-12.1% YoY
|
4.08B
3.98B – 4.15B
+3.6% YoY
|
5.88B
5.74B – 5.99B
+44.1% YoY
|
| SGA |
7.51B
est: 6.98B (+7.6%)
|
8.79B
est: 7.58B (+16.0%)
|
10.13B
est: 8.99B (+12.7%)
|
11.54B
est: 10.09B (+14.3%)
|
11.51B
est: 11.06B (+4.0%)
|
12.74B
est: 12.12B (+5.1%)
|
13.69B
est: 13.47B (+1.7%)
|
14.59B
est: 14.43B (+1.1%)
|
13.73B
est: 14.54B (-5.6%)
|
14.92B
14.89B – 14.95B
+2.6% YoY
|
15.43B
15.24B – 15.55B
+3.4% YoY
|
15.89B
15.53B – 16.23B
+3.0% YoY
|
15.64B
15.36B – 15.87B
-1.6% YoY
|
16.62B
16.33B – 16.87B
+6.3% YoY
|
| EPS |
28.51
est: 26.27 (+8.5%)
|
9.84
est: 30.03 (-67.2%)
|
37.49
est: 37.40 (+0.2%)
|
50.32
est: 54.86 (-8.3%)
|
37.50
est: 40.14 (-6.6%)
|
37.07
est: 46.58 (-20.4%)
|
33.52
est: 44.38 (-24.5%)
|
24.10
est: -3.01 (+900.9%)
|
42.93
est: 43.79 (-2.0%)
|
47.75
45.60 – 50.01
+9.0% YoY
|
48.05
44.32 – 52.75
+0.6% YoY
|
52.95
31.13 – 66.21
+10.2% YoY
|
44.20
43.18 – 45.03
-16.5% YoY
|
63.70
62.22 – 64.90
+44.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
7.47B
OE per share TTM
81.41
Owner's Yield
7.35%
Maintenance CapEx ratio
4.51%
Maint CapEx / Avg PPE
11.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L | 0.00% | 33.4K | 0.45% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
216.8K
Shares Outstanding
91.00M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kazuhiro Mashihara | Senior Managing Corporate Officer, Chief Information Officer & Director | — | male |
| Naoki Yoshida | Managing Corporate Officer | — | — |
| Satoshi Yokota | Head of the Corporate Management Division | — | — |
| Toru Noda | Chief Executive Officer, President & Representative Director | — | male |
| Yuichi Katano | Managing Corporate Officer & GM of Elderly Care Business Division | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6197.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
